Analgesics - Oman

  • Oman
  • In 2024, the revenue in the Analgesics market in Oman amounts to US$61.81m.
  • It is projected to grow annually by 5.08% (CAGR 2024-2029).
  • When compared globally, the in the United States generates the highest revenue in this market, amounting to US$7,243.00m in 2024.
  • In relation to the total population of Oman, per person revenues of US$13.11 are generated in 2024.
  • Oman's market for OTC analgesics is witnessing a surge in demand, driven by the increasing prevalence of chronic pain conditions among the aging population.

Key regions: Canada, United States, United Kingdom, Australia, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics market in Oman has been experiencing significant growth in recent years. Customer preferences for pain relief products, along with various trends in the market, have contributed to this development. Additionally, local special circumstances and underlying macroeconomic factors have played a role in shaping the market.Customer preferences in Oman favor analgesics that provide effective pain relief with minimal side effects. Consumers are increasingly seeking out products that offer quick and long-lasting relief from various types of pain, including headaches, muscle aches, and joint pain. This preference for high-quality pain relief has driven the demand for analgesics in the market.One trend in the market is the increasing popularity of natural and herbal analgesics. Many consumers in Oman are turning to natural remedies and seeking products that are perceived to be safer and have fewer side effects. This trend is in line with the global shift towards natural and organic products. As a result, manufacturers are introducing more natural and herbal options in the analgesics market to cater to this growing demand.Another trend in the market is the rising prevalence of chronic diseases and conditions that require long-term pain management. The aging population and changing lifestyles have contributed to an increase in chronic pain cases in Oman. This has led to a higher demand for analgesics that provide sustained pain relief over an extended period. Manufacturers are responding to this trend by developing and promoting analgesics specifically designed for long-term pain management.Local special circumstances in Oman have also influenced the development of the Analgesics market. The country has a high prevalence of chronic diseases, such as diabetes and cardiovascular diseases, which often require pain management. Additionally, the hot climate in Oman can exacerbate certain types of pain, such as headaches and muscle aches. These factors have contributed to the increased demand for analgesics in the market.Underlying macroeconomic factors have further supported the growth of the Analgesics market in Oman. The country has experienced steady economic growth and rising disposable incomes, which have increased consumers' purchasing power. This has allowed more people to afford analgesics and contribute to the market's expansion. Additionally, the government's focus on improving healthcare infrastructure and services has also contributed to the growth of the market.In conclusion, the Analgesics market in Oman is developing due to customer preferences for effective pain relief, trends such as the popularity of natural and herbal analgesics, local special circumstances such as the prevalence of chronic diseases, and underlying macroeconomic factors such as economic growth and improved healthcare infrastructure.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Key Players
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)